Discontinuation report HUMALOG
Report ID | 224347 |
Drug Identification Number | 02229704 |
Brand name | HUMALOG |
Common or Proper name | insulin lispro injection |
Company Name | ELI LILLY CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | INSULIN LISPRO |
Strength(s) | 100UNIT |
Dosage form(s) | SOLUTION |
Route of administration | SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR |
Packaging size | Vial VL7533, 3 mL, 100 units/mL |
ATC code | A10AB |
ATC description | INSULINS AND ANALOGUES |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2024-12-20 |
Actual discontinuation date | |
Remaining supply date | 2024-12-20 |
Discontinuation status | To be discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | Only the 3 mL vial presentation (Vial VL7533, 3 mL, 100 units/mL) is being discontinued, anticipated remaining supply date may be impacted based on any changes in demand. The following presentations remain available: Humalog 10 mL, 100 units/mL, Vial VL7510 (same DIN 02229704), Humalog 3.0 mL, 100 units /mL, 5 cartridges/box VL7516 (DIN 02229705), Humalog 3.0 mL prefilled pen, 100 units/mL, KwikPen HP8799 (DIN 02403412), Humalog 3.0 mL prefilled pen, 100 units/mL, Junior KwikPen HP7714 (DIN 02470152) |
Company comments | Humalog 3 mL vial presentation shares a DIN with the 10 mL vial presentation (02229704). Humalog 10 mL vial presentation will continue to be available. For any questions, please contact our Customer Response Centre at 1-888-545-5972 (Monday-Friday, 9 a.m. to 5 p.m. Eastern Time, excluding holidays). |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | EXCHANGE TOWER, 130 KING STREET WEST TORONTO, ONTARIO CANADA M5X 1B1 |
Company contact information | Lilly Canada’s Customer Response Centre 1-888-545-5972. |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2024-04-04 | English | Compare |
v2 | 2024-04-04 | French | Compare |
v3 | 2024-06-21 | English | Compare |
v4 | 2024-06-21 | French | Compare |
v5 | 2024-09-05 | English | Compare |
v6 | 2024-09-05 | French | Compare |
v7 | 2024-09-27 | English | Compare |
v8 | 2024-09-27 | French | Compare |
v9 | 2024-10-02 | English | Compare |
v10 | 2024-10-02 | French | Compare |
v11 | 2024-10-15 | English | Compare |
v12 | 2024-10-15 | French | Compare |
v13 | 2024-10-22 | English | Compare |
v14 | 2024-10-22 | French | Compare |
v15 | 2024-10-29 | English | Compare |
v16 | 2024-10-29 | French | Compare |
v17 | 2024-11-14 | English | Compare |
v18 | 2024-11-14 | French | Compare |
v19 | 2024-11-27 | English | Compare |
v20 | 2024-11-27 | French | Compare |